Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

IL-17 and certain immune cells are linked to more severe alopecia areata.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

γδ T cells adapt uniquely to different tissues in mice.

TLR3 activation helps improve skin and hair follicle healing in mice.

CMV infection increases the risk of GvHD after bone marrow transplants.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Enhancing immune response can improve cancer treatment effectiveness.

CD133+ cells are crucial for hair growth.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

CS12192 effectively treats alopecia areata with better safety than current options.

Human thymus has stem cells that can self-renew and maintain their identity.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Targeting specific T cells may help treat alopecia areata.